The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more expensive medicines.
Cigna Demands FTC Retraction in Escalating Drug-Price Fight
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more expensive medicines.